ICO HeadStart™ is the safest ICO fundraising platform in the world. Our experienced team of compliance experts award only carefully selected ICOs with a seal of approval after screening before these ICOs get listed on the ICO HeadStart™ platform adhering to give our community access to the best possible ICO proposals and the highest security standards in the ecosystem. In return for ETH and BTC the community receives MOAT along with voting points. Through voting the community decides which of these ICOs get funded. Elected projects receive their funds through Escrow 2.0 after the smart contract conditions have been met. ICO HeadStart's profits will be shared for 100%: 80% will be used to exchange back MOAT from the community and 20% will be used to give funded ICOs a head start. Decentralized, transparant, simple, honest.

Forget fragmented marketplaces! NOBAR is creating the first ever "Unified Crypto Commerce" to provide a holistic solution to the purchasing problem with cryptocurrency and crypto token. Our two robust functions - "Crypto Commerce" and "Shop-App" will facilitate all possible commercial activities.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.

At its core, Nice 1 is a blockchain game development platform. When using Nice 1, a game developer can raise funds from public and private supporters. However, Nice 1 goes further than just mere fundraising. The Nice 1 blockchain provides users with access to an SDK library (and documentation) for Unreal Engine & Unity. Nice 1 is striving to create state-of-the-art gaming services for streamers and esports enthusiasts. Non-game developers can earn and support gamers and developers, by helping support the Nice 1 blockchain network. The primary goal of Nice 1, is to promote innovation in gaming worldwide. However, in the process, Nice 1 is also striving to tackle increasing censorship in gaming.

INVERSE is a DeFi based platform that provides an array of smart-contract features with integrated time-based options. Users have the opportunity to speculate on the drop in value of a suite of Defi coins by utilizing the multiple 'tracking vaults' on the platform. XIV, the protocol's native token, is used to unlock these vaults, and then staked within these vaults for no more than 7 days. As their name implies, these vaults track the real-time price movements of select DeFi tokens (i.e. COMP, AAVE, UNI, YFI). After 7 days, if the value of the DeFi asset being tracked has dropped by a certain percentage, the user will gain a significant percentage yield on the amount of XIV held within the tracking vault. If the price of the DeFi asset does not drop in value beyond the predetermined percentage by the end of the 7-day staking period, the user will forfeit a portion of their staked XIV. Rewards will be automatically disbursed to the user’s web3 browser wallet at the end of the 7-day staking period. Ultimately, INVERSE offers users the option to hedge against the volatility of select crypto assets.

MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.